Detalhe da pesquisa
1.
Mucosal boosting enhances vaccine protection against SARS-CoV-2 in macaques.
Nature
; 626(7998): 385-391, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38096903
2.
A Double-Blind, Randomized, Placebo-Controlled Phase 1 Study of Ad26.ZIKV.001, an Ad26-Vectored Anti-Zika Virus Vaccine.
Ann Intern Med
; 174(5): 585-594, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33587687
3.
Magnitude and Quality of Cytokine and Chemokine Storm during Acute Infection Distinguish Nonprogressive and Progressive Simian Immunodeficiency Virus Infections of Nonhuman Primates.
J Virol
; 90(22): 10339-10350, 2016 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27630228
4.
CoPoP liposomes displaying stabilized clade C HIV-1 Env elicit tier 2 multiclade neutralization in rabbits.
Nat Commun
; 15(1): 3128, 2024 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38605096
5.
A rationally engineered anti-HIV peptide fusion inhibitor with greatly reduced immunogenicity.
Antimicrob Agents Chemother
; 57(2): 679-88, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23147734
6.
Memory CD4(+) T lymphocytes in the gastrointestinal tract are a major source of cell-associated simian immunodeficiency virus in chronic nonpathogenic infection of African green monkeys.
J Virol
; 86(20): 11380-5, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22896600
7.
Intravenous Administration of Ad26.COV2.S Does Not Induce Thrombocytopenia or Thrombotic Events or Affect SARS-CoV-2 Spike Protein Bioavailability in Blood Compared with Intramuscular Vaccination in Rabbits.
Vaccines (Basel)
; 11(12)2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38140195
8.
Combination Ad26.RSV.preF/preF protein vaccine induces superior protective immunity compared with individual vaccine components in preclinical models.
NPJ Vaccines
; 8(1): 45, 2023 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36949051
9.
Booster with Ad26.COV2.S or Omicron-adapted vaccine enhanced immunity and efficacy against SARS-CoV-2 Omicron in macaques.
Nat Commun
; 14(1): 1944, 2023 04 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37029141
10.
High cell-free virus load and robust autologous humoral immune responses in breast milk of simian immunodeficiency virus-infected african green monkeys.
J Virol
; 85(18): 9517-26, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21734053
11.
Suppression of adaptive immune responses during primary SIV infection of sabaeus African green monkeys delays partial containment of viremia but does not induce disease.
Blood
; 115(15): 3070-8, 2010 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20147699
12.
Sequential use of Ad26-based vaccine regimens in NHP to induce immunity against different disease targets.
NPJ Vaccines
; 7(1): 146, 2022 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36379957
13.
Immunogenicity and protective efficacy of adenoviral and subunit RSV vaccines based on stabilized prefusion F protein in pre-clinical models.
Vaccine
; 40(6): 934-944, 2022 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34973849
14.
Durability and expansion of neutralizing antibody breadth following Ad26.COV2.S vaccination of mice.
NPJ Vaccines
; 7(1): 23, 2022 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35197477
15.
Passive transfer of Ad26.COV2.S-elicited IgG from humans attenuates SARS-CoV-2 disease in hamsters.
NPJ Vaccines
; 7(1): 2, 2022 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35013325
16.
Inhibition of adaptive immune responses leads to a fatal clinical outcome in SIV-infected pigtailed macaques but not vervet African green monkeys.
PLoS Pathog
; 5(12): e1000691, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20011508
17.
Ad26.COV2.S protects Syrian hamsters against G614 spike variant SARS-CoV-2 and does not enhance respiratory disease.
NPJ Vaccines
; 6(1): 39, 2021 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33741993
18.
Immunogenicity and efficacy of one and two doses of Ad26.COV2.S COVID vaccine in adult and aged NHP.
J Exp Med
; 218(7)2021 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33909009
19.
Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses.
NPJ Vaccines
; 5: 91, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33083026
20.
Comparison of shortened mosaic HIV-1 vaccine schedules: a randomised, double-blind, placebo-controlled phase 1 trial (IPCAVD010/HPX1002) and a preclinical study in rhesus monkeys (NHP 17-22).
Lancet HIV
; 7(6): e410-e421, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32078815